Sustainable Early Episode Clinic Study (SEEC)
SEEC
A Prospective, Open Label, Quasi-Experimental Study of Adult Patients With Schizophrenia or Schizoaffective Disorder Within Five Years of Diagnosis Who Will Receive SEEC Intervention
1 other identifier
interventional
50
1 country
1
Brief Summary
The purpose of this study is to describe relapse rates among participants receiving services in the SEEC program high intensity resource use. For purposes of this study, relapse will be defined as: Psychiatric hospitalization; Psychiatric emergency department visits; Ambulatory acute services (Partial Hospitalization Program, Intensive Outpatient Program, Crisis House stay).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable schizophrenia
Started Jan 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 31, 2017
CompletedFirst Submitted
Initial submission to the registry
March 1, 2018
CompletedFirst Posted
Study publicly available on registry
June 27, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 20, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 20, 2019
CompletedApril 27, 2025
April 1, 2025
2.9 years
March 1, 2018
April 25, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
High Intensity Service Utilization Rate
The rate of high intensity service utilization that is count per unit of time for mental health services will be reported. It is evaluated as the number of psychiatric hospitalizations, behavioral health emergency department visits, and number of times referred to a partial hospitalization program (PHP), intensive outpatient program (IOP), or Crisis Unit.
Baseline up to 36 months
Secondary Outcomes (6)
Overall Healthcare Utilization Rate
Baseline up to 36 months
Change from Baseline in Clinician-Rated Dimensions of Psychosis Symptom and Severity (CRDPSS) Scale
Baseline up to 36 months
Change from Baseline in Clinical Global Impressions Scale (CGI-S)
Baseline up to 36 months
Change from Baseline in Personal and Social Performance (PSP) Scale
Baseline up to 36 months
Change from Baseline in Perceived Family Burden Scale (PFBS)
Baseline up to 36 months
- +1 more secondary outcomes
Study Arms (1)
Sustainable Early Episode Clinic Model of Care
EXPERIMENTALThe model of care given in the sustainable early episode clinic study, provides early intense intervention, with an ongoing maintenance phase in an outpatient setting.
Interventions
The first 8 weeks is the education phase. Participants attend classes every week for up to 6 hours. From 9 weeks to 10 months participants attend classes for 5 hours every other week. Based on individual progress. Participants can move to the maintenance phase. This phase provides minimal intervention but ongoing support/evaluation.
Eligibility Criteria
You may qualify if:
- Participants must be at least 18 years or older
- Participants within 5 years of a clinical diagnosis of Schizophrenia or Schizoaffective disorder made by a clinician with understanding of the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria for these disorders
- Participants must be able to speak, read, and understand English
- Participants must sign an informed consent form
- Caregivers must be 18 years or older Caregivers must also be willing to attend the multi-family psychoeducation group series (Phase I)
- Caregivers must be willing to participate in monthly family therapy and/or monthly phone contact with staff for the duration of the study
- Caregivers must sign informed consent form
You may not qualify if:
- Co-occurring developmental disabilities
- Receiving electroconvulsive therapy
- Primary substance use disorder
- On permanent conservatorship
- Unable to complete baseline assessments due to acuity of psychiatric symptoms
- Caregivers who refuse to participate in the psychoeducation series of Phase 1
- Caregivers who refuse monthly family therapy/phone contact with staff will be excluded
- Caregiver is mentally or physically incapable of adequately performing the required study procedures, as determined by treatment team
- Caregiver is an employee of the investigator or study site, with direct involvement in the proposed study or other studies under the direction of that investigator or study site, as well as family members of the employee or the investigator
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sharp Outpatient Behavioral Health Clinic
San Diego, California, 92105, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Janssen Scientific Affairs, LLC Clinical Trial
Janssen Scientific Affairs, LLC
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 1, 2018
First Posted
June 27, 2018
Study Start
January 31, 2017
Primary Completion
December 20, 2019
Study Completion
December 20, 2019
Last Updated
April 27, 2025
Record last verified: 2025-04